| 查看: 2367 | 回复: 23 | |||
[交流]
帮我分析分析是否中稿呢
|
|||
|
前段时间在IOP上投了篇文章,编辑回复如下: Thank you for your submission which will be considered for publication in *************. The reference number for your article is ********. Please quote this number in all future correspondence regarding this article. 还让填一份assignment of copyright ASSIGNMENT OF COPYRIGHT and DECLARATION OF RESPONSIBILITY 1. IOP Publishing Ltd ("the Publisher" agrees to publishManuscript title: ********************* ("The Article" written by Names of all Authors: ****************************("the Named Authors" ![]() in the following journal: **********************("the Journal" ![]() 2. Transfer of Copyright Agreement 2.1 On acceptance for publication the undersigned author(s) (“Author”) of the Article assigns exclusively to IOP worldwide copyright in the Article for the full term and for all media and formats in all material published as part of the Article, which expression includes but is not limited to the text, abstract, tables, figures and graphs, but excludes any supplementary material. 2.2 If any of the Named Authors are Government employees, on acceptance for publication the Author shall grant IOP a royalty free exclusive licence for the full term of copyright for all media and formats to do in relation to the Article all acts restricted by copyright worldwide. 2.3 On acceptance for publication the Author shall grant IOP a royalty free non-exclusive licence for the full term of copyright for all media and formats to do in relation to any supplementary material deemed to be part of the Article all acts restricted by copyright worldwide. 3. Author Rights 3.1 IOP grants the Named Authors the rights specified in 3.2 and 3.3. All such rights must be exercised for non-commercial purposes, if possible should display citation information and IOP’s copyright notice, and for electronic use best efforts must be made to include a link to the on-line abstract in the Journal. Exercise of the rights in 3.3 additionally must not use the final published IOP format but the Named Author’s own format (which may include amendments made following peer review). 3.2 The rights are: 3.2.1 To make copies of the Article (all or part) for teaching purposes; 3.2.2 To include the Article (all or part) in a research thesis or dissertation; 3.2.3 To make oral presentation of the Article (all or part) and to include a summary and/or highlights of it in papers distributed at such presentations or in conference proceedings; and 3.2.4 All proprietary rights other than copyright. 3.3 The additional rights are to: 3.3.1 Use the Article (all or part) without modification in personal compilations or publications of a Named Author’s own works (provided not created by third party publisher); 3.3.2 Include the Article (all or part) on a Named Author’s own personal web site; 3.3.3 Include the Article (all or part) on web sites of the Institution (including its repository) where a Named Author worked when research for the Article was carried out; and 3.3.4 Include the Article (all or part) on third party web sites including e-print servers, but not on other publisher’s web sites. Signature In signing this Agreement the Author represents and warrants that the Article is the original work of the Named Authors, it has not been published previously in any form (other than as permitted under clause 3.2.2 which fact has been notified to IOP in writing), all Named Authors have participated sufficiently in the conception and writing of the Article, have received the final version of the Article, agree to its submission and take responsibility for it, and submission has been approved as necessary by the authorities at the establishment where the research was carried out. The Author warrants that he/she signs this Agreement as authorised agent for all Named Authors and has the full power to enter into this Agreement and to make the grants it contains, that the Article has not been and will not be submitted to another publisher prior to withdrawal or rejection, it does not infringe any third party rights, it contains nothing libellous or unlawful, all factual statements are to the best of the Author’s knowledge true or based on valid research conducted according to accepted norms, and all required permissions have been obtained in writing. All Named Authors assert their moral rights. Author’s signature………………………………………....………….Date…………………… Signature on behalf of Institution………………………………………Date……………………. |
» 猜你喜欢
遇见不省心的家人很难过
已经有10人回复
博士延得我,科研能力直往上蹿
已经有3人回复
退学或坚持读
已经有24人回复
免疫学博士有名额,速联系
已经有14人回复
面上基金申报没有其他的参与者成吗
已经有4人回复
多组分精馏求助
已经有6人回复
» 本主题相关价值贴推荐,对您同样有帮助:
请大家帮我分析这个产物能不能过柱纯化呢?
已经有27人回复
麻烦大家帮我分析分析
已经有4人回复
各位大牛,帮我分析下出国公派读博,是不是离我越来越远了?
已经有27人回复
大家帮我分析下导师的答复,是不是没有什么希望,谢谢大家了!!!
已经有5人回复
这个导师是什么意思呢,大家帮我分析一下吧。
已经有46人回复
哪位高手帮我分析这张幅循环伏安曲线呢
已经有12人回复
北京和深圳,哪个好呢?请大家帮我分析下
已经有28人回复
大家帮我分析分析
已经有4人回复
【求助】大家来帮我分析下是不是要这么久
已经有14人回复
大家帮我分析一下有没有这种可能呢?谢谢
已经有13人回复
» 抢金币啦!回帖就可以得到:
南方医科大学中药学院 申请考核博士一名 (天然药化方向,天然产物分离经验优先)
+1/272
Postdoctoral Research Fellow Position in Causal Inference Weill CorneIl Medicine
+1/92
电力全国重点实验室双一流A类长江学者团队招2026年全日制博士1-2名/博士后
+2/68
博后平台选择
+1/63
西交利物浦大学招收26年【全奖】博士生1名(空间智能沉浸式手术导航)
+1/40
山东科技大学招聘化学化工博士博士后
+1/28
中科院深圳先进院-免疫治疗方向-招收1名博士生(26年9月入学)
+1/15
西班牙巴塞罗那访学、博后、留学互动
+1/11
青岛大学招收少数民族【少干计划】生物与医药博士研究生
+1/9
太原理工大学集成电路学院院长团队招收2026年博士研究生
+1/8
苏州大学招收申请考核制博士生、博士后(2026)
+1/6
《中文期刊点评》这个模块,怎么不能点评期刊了呢自动跳转到主页了
+1/5
复旦大学化学系凡勇教授/张凡教授团队招聘博士后
+1/4
海南大学化学院—功能分子器件团队2026博士/研究助理招生+博士后招聘
+1/4
英国兰卡斯特大学(Lancaster University)大模型、计算机视觉PhD招生
+1/4
山东大学集成电路学院王凌云研究员招收2026年硕士生及联合培养硕士生
+1/3
211大学-课题组招收学术博士生
+1/3
武汉工程大学董志兵教授课题组招收博士/硕士研究生(长期有效)
+1/2
海南大学国家优青团队招聘“AI/大数据+材料”方向专任教师(事业编制)
+1/1
大连工业杰青、长江团队-生物质材料方向招收2026级博士生
+1/1
2楼2011-03-31 15:48:33
3楼2011-03-31 16:13:08
4楼2011-03-31 16:19:31
5楼2011-03-31 16:20:59
6楼2011-03-31 16:23:04
7楼2011-03-31 16:24:25
8楼2011-03-31 16:25:06
10楼2011-03-31 17:11:57
11楼2011-03-31 20:11:42
12楼2011-04-01 09:09:11
13楼2011-04-01 09:11:12
14楼2011-04-01 09:12:57
15楼2011-04-01 09:14:24
16楼2011-04-01 09:15:28
17楼2011-04-01 09:16:10
18楼2011-04-01 09:16:47
19楼2011-04-01 09:17:31
20楼2011-04-01 09:18:25
21楼2011-04-01 09:50:16
22楼2011-04-05 12:42:01
23楼2011-04-05 21:33:45
24楼2012-11-04 11:01:26
简单回复
2011-03-31 16:54
回复













agrees to publish
回复此楼

